Search

01/09/2021 Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19
Buxeda, A, Arias-Cabrales, C, Perez-Saez, MJ, Cacho, J, Pelegrin, SC, Melilli, E, Aladren, MJ, Galeano, C, Lorenzo, I, Mazuecos, A, Saura, IM, Franco, A, Ruiz-Fuentes, MD, Sanchez-Camara, LA, Siverio, O, Martin, ML, Gonzalez-Garcia, E, Lopez, V, Martin-Moreno, PL, Moina, I, Berrio, EM, Moreso, F, Portoles, JM, Santana-Estupinan, R, Zarraga, S, Canal, C, Sanchez-Alvarez, E, Pascual, J, Crespo, M. Use and Safety of Remdesivir in Kidney Transplant Recipients With COVID-19. Kidney International Reports. 2021; 6(9)DOI:10.1016/j.ekir.2021.06.023. PMID:34250317. IF:6.234(Q1/2D).
01/09/2021 A urinary stone from the early medieval site of Riner, Catalonia
Oller, NA, Gracia-Gracia, S, Cugat, JB, Vicente, IG, Exposito, IM, Casafont, JL. A urinary stone from the early medieval site of Riner, Catalonia. International Journal of Paleopathology. 2021; 34DOI:10.1016/j.ijpp.2021.07.006. PMID:34315047. IF:1.448(Q3/8D).
01/08/2021 Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation
Millan, O, Rovira, J, Guirado, L, Espinosa, C, Budde, K, Sommerer, C, Pineiro, GJ, Diekmann, F, Brunet, M. Advantages of plasmatic CXCL-10 as a prognostic and diagnostic biomarker for the risk of rejection and subclinical rejection in kidney transplantation. CLINICAL IMMUNOLOGY. 2021; 229DOI:10.1016/j.clim.2021.108792. PMID:34217849. IF:10.190(Q1/2D).
01/08/2021 Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria
Savige, J, Storey, H, Watson, E, Hertz, JM, Deltas, C, Renieri, A, Mari, F, Hilbert, P, Plevova, P, Byers, P, Cerkauskaite, A, Gregory, M, Cerkauskiene, R, Ljubanovic, DG, Becherucci, F, Errichiello, C, Massella, L, Aiello, V, Lennon, R, Hopkinson, L, Koziell, A, Lungu, A, Rothe, HM, Hoefele, J, Zacchia, M, Martic, TN, Gupta, A, van Eerde, A, Gear, S, Landini, S, Palazzo, V, Al-Rabadi, L, Claes, K, Corveleyn, A, Van Hoof, E, van Geel, M, Williams, M, Ashton, E, Belge, H, Ars, E, Bierzynska, A, Gangemi, C, Lipska-Zietkiewicz, BS. Consensus statement on standards and guidelines for the molecular diagnostics of Alport syndrome: refining the ACMG criteria. EUROPEAN JOURNAL OF HUMAN GENETICS. 2021; 29(8)DOI:10.1038/s41431-021-00858-1. PMID:33854215. IF:5.351(Q1/2D).
01/08/2021 Next-generation sequencing in patients with familial FSGS: first report of collagen gene mutations in Tunisian patients
Ammar, S, Kanoun, H, Kammoun, K, Domingo-Gallego, A, Ruiz, P, Lorente-Grandoso, L, Pybus, M, Maalej, B, Boudawara, T, Kamoun, H, Ben Hmida, M, Ars, E, Jarraya, F. Next-generation sequencing in patients with familial FSGS: first report of collagen gene mutations in Tunisian patients. JOURNAL OF HUMAN GENETICS. 2021; 66(8)DOI:10.1038/s10038-021-00912-2. PMID:33654185. IF:3.767(Q2/5D).
01/08/2021 Genetic kidney diseases as an underrecognized cause of chronic kidney disease: the key role of international registry reports
Torra, R, Furlano, M, Ortiz, A, Ars, E. Genetic kidney diseases as an underrecognized cause of chronic kidney disease: the key role of international registry reports. Clinical Kidney Journal. 2021; 14(8)DOI:10.1093/ckj/sfab056. PMID:34345410. IF:5.860(Q1/2D).